Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: J Heart Lung Transplant. 2016 Jan 15;35(6):714–721. doi: 10.1016/j.healun.2016.01.016

Figure 5.

Figure 5

NT-proBNP sensitivity analysis within validation cohort. Calibration histograms shown: one-year observed mortality, cardiac transplantation or ventricular assist device implantation (red bar) and SHFM-predicted mortality risk (pink bar). Patients are stratified within the pre-specified categories of clinically relevant one-year risk [low (≤2.5%), intermediate (2.5–≤10%), and high risk (>10%)] according to SHFM -predicted probabilities and subsequently according to NT-proBNP levels above (↑) or below (↓) the optimal partition-value (NT-proBNP > 1100) based on ROC-analysis in the validation cohort.